On 17 January 2012, the Italian Competition Authority (“Autorità Garante della Concorrenza e del Mercato”) announced that it had fined pharmaceutical group Pfizer € 10.6 million for abuse of dominance in the market for
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.